Revised forecast
Fiscal year ending March 2027 · Second quarter (interim period) and full yearPrevious forecast published 13 May 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
The inks, chemicals and processed products businesses performed solidly, and net sales and profit exceeded the initial plan as a result of strengthened sales, the acquisition of new customers and a shift toward high-value-added products. While assuming that the impact of surging raw material prices and price revisions by suppliers will continue in the second half, the forecasts have been revised upward based on the earnings outlook through the interim period and the business environment.
| Item | Details |
|---|---|
| Net Sales | Interim period 23,800 / Full year 48,900 → Interim period 26,500 / Full year 54,300（Interim period 11.3 / Full year 11） |
| Operating profit | Interim period 600 / Full year 1,800 → Interim period 1,300 / Full year 2,700（Interim period 116.7 / Full year 50） |
| Ordinary income | Interim period 700 / Full year 1,950 → Interim period 1,430 / Full year 2,900（Interim period 104.3 / Full year 48.7） |
| Profit attributable to owners of the parent | Interim period 800 / Full year 1,950 → Interim period 1,400 / Full year 2,650（Interim period 75 / Full year 35.9） |
| Net income per share | Interim period 64.02 / Full year 156.06 → Interim period 112.05 / Full year 212.09 |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Second quarter (interim period) and full year |
| Publication date of previous forecast | 13 May 2026 |
| Previous-period results | Interim period Net sales: ¥24,336 million; operating income: ¥1,096 million; ordinary income: ¥1,203 million; interim net income attributable to owners of the parent: ¥785 million; interim net income per share: ¥61.73 / Full year Net sales: ¥49,926 million; operating income: ¥2,217 million; ordinary income: ¥2,454 million; net income attributable to owners of the parent: ¥1,867 million; net income per share: ¥147.44 |
| Reason for the revision | The inks, chemicals and processed products businesses performed solidly, and net sales and profit exceeded the initial plan as a result of strengthened sales, the acquisition of new customers and a shift toward high-value-added products. While assuming that the impact of surging raw material prices and price revisions by suppliers will continue in the second half, the forecasts have been revised upward based on the earnings outlook through the interim period and the business environment. |
| Dividend forecast revision | The interim dividend has been increased from ¥30 to ¥50 per share, the year-end dividend from ¥35 to ¥45, and the annual dividend from ¥65 to ¥95. Increases from the previous forecasts are ¥20, ¥10 and ¥30 per share for the interim, year-end and annual dividends, respectively. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the inks business, offset inks exceeded plan as a result of strengthened sales to key customers and the acquisition of new customers. Functional inks and coating agents, as well as gravure inks for medical packaging, also performed well. In the chemicals business, profitability improved due to market conditions in mobility applications, market-share expansion and a shift toward high-value-added products, while the processed products business also remained solid. Based on these developments, the interim-period and full-year forecasts have been revised upward, while assuming that surging raw material prices and price revisions by suppliers will continue in the second half.